Volume 22, 2018 Library CD

Volume 22, 2018 Archive

Six issues from 2018 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issue/Volume	Title
Issues Included
January/February 2018 Vol. 22 No. 1	Volume 22, Number 1
March/April 2018 Vol. 22 No. 2	Volume 22, Number 2
May/June 2018 Vol. 22 No. 3	Volume 22, Number 3
July/August 2018 Vol. 22 No. 4	Volume 22, Number 4
September/October 2018 Vol. 22 No. 5	Volume 22, Number 5
November/December 2018 Vol. 22 No. 6	Volume 22, Number 6

Volume 22, 2018 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2018 Pg. 4	PreScription: 2017--Some Good Things Happened and Some Others Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 7-16	Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018 Pg. 19-24	Pain: Systematic Review of Pharmacy Compounding of Pain Medication Author(s): Shawaqfeh Mohammad S, Harrington Catherine
Jan/Feb 2018 Pg. 26-28	The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Author(s): Blankenship Cynthia
Jan/Feb 2018 Pg. 30-39	Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients Author(s): McElhiney Linda F
Jan/Feb 2018 Pg. 41-46	Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Author(s): Kosinski Tracy M, Brown Michael C, Zavala Pedro J
Jan/Feb 2018 Pg. 48	Calculations Author(s): Stockton Shelly J
Jan/Feb 2018 Pg. 50	Glutamate and Aspartate Cardioplegia Additive Solution Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 51	Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 52	Metronidazole 50 mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 53	Miconazole 10% in Recura Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 54	Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 55	Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 56	Ranitidine 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 59	Voriconazole 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 60-65	Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Author(s): Song Guiyun, Banov Daniel, Bassani August S
Jan/Feb 2018 Pg. 66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 95-107	Pharmacogenomics: Precision Pharmacy in 503A Compounding Author(s): Drummond Joseph, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018 Pg. 125-126	IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Author(s): Blankenship Cynthia
Mar/Apr 2018 Pg. 129-134	Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Author(s): Rhoads Rick
Mar/Apr 2018 Pg. 137-143	Basics of Compounding: Compounding Microemulsions Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 144	Calculations Author(s): Stockton Shelly J
Mar/Apr 2018 Pg. 146	Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 147	Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 148	Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 149	Levodopa and Carbidopa Rectal Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 150	Prochlorperazine Edisylate 0.5% Nasal Spray Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 152	Spironolactone 5-mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 153	Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 154-163	Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats Author(s): Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
Mar/Apr 2018 Pg. 164-171	The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions Author(s): Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
Mar/Apr 2018 Pg. 172-175	Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
May/Jun 2018 Pg. 180	PreScription: Influence and Sphere of Influence Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 182-188	Pitch Ointment: Applications in Scar and Wound Management Author(s): Kloesel Lawson, Carvalho Maria, Banov Fabiana
May/Jun 2018 Pg. 190-195	Establishing a Rationale for Compounding Hormone Replacement Therapy Author(s): Biundo Bruce
May/Jun 2018 Pg. 196-202	Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications Author(s): Agbi Kelechi E, Hover Sara, Carvalho Maria
May/Jun 2018 Pg. 204-205	Your Presence is Needed at Compounders on Capitol Hill! Author(s): Blankenship Cynthia
May/Jun 2018 Pg. 206-217	Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 220-228	Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 230	Calculations Author(s): Stockton Shelly J
May/Jun 2018 Pg. 232	Anhydrous Silicon Base Topical Gel Vehicle Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 233	Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 234	Dorzolamide 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 235	Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 236	Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 238	Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 239	Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 240-246	Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals Author(s): Khokhlova Kateryna O, Zdoryk Oleksandr A
May/Jun 2018 Pg. 247-251	Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations Author(s): Visser J Carolina, ten Seldam Inge E J, van der Linden Isabella J, Hinrichs Wouter L J, Veenendaal Reinier F H, Dijkers Eli C F, Woerdenbag Herman J
May/Jun 2018 Pg. 252-256	The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Author(s): Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa
May/Jun 2018 Pg. 257-263	Trace Level Analysis of Airborne Hormone Particulates Author(s): Trimble John O, Hampton Shanna
May/Jun 2018 Pg. 263	Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension Author(s):
Jul/Aug 2018 Pg. 268	PreScription: Factors Related to Drug Waste and Pharmacy Solutions Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018 Pg. 281-283	Compounding from a Pharmacy Student's Perspective Author(s): Gochenauer Alexandria
Jul/Aug 2018 Pg. 284-287	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Author(s): Williams LaVonn
Jul/Aug 2018 Pg. 288-293	Quality Control: Water Activity Considerations for Beyond-use Dates Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 294-300	Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 303-312	Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Author(s): Martin Matt
Jul/Aug 2018 Pg. 314	Calculations Author(s): Stockton Shelly J
Jul/Aug 2018 Pg. 316	Anhydrous Medium-chain Triglycerides Gel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 317	Budesonide 1-mg//10-mL Mucolox Oral Suspensions Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 318	Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 319	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 320	Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 321	Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 322	Minoxidil 50 mg/mL in Espumil Foam Base Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 323	Oseltamivir Phosphate 15 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 324	Pentoxifylline 5% in Dermabase Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 325	Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 326-328	Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension Author(s): Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J
Jul/Aug 2018 Pg. 329-334	Kinetics of Tetracaine Solvolysis in Propylene Glycol Author(s): McPherson Timothy B, Neumann William L, Goolsby Michael, Kolling William M
Jul/Aug 2018 Pg. 335-339	Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M
Jul/Aug 2018 Pg. 340-344	Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes Author(s): Huffman Jessica, Brown Stacy, Lewis Paul, Lawson Sarah, Ogle Amanda, Peacock Gina
Jul/Aug 2018 Pg. 345-349	Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Author(s): Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
Sep/Oct 2018 Pg. 356	PreScription: Updating Formulations Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
Sep/Oct 2018 Pg. 369-384	Certification of Powder-containment Hoods for Nonsterile Compounding Author(s): Mulder Kyle, Dozzi Raphael
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2018 Pg. 401-404	Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Author(s): Martin Matt
Sep/Oct 2018 Pg. 406	Calculations Author(s): Stockton Shelly J
Sep/Oct 2018 Pg. 408	Cysteamine 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 410	Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 411	Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 412-416	Stability of Tranexamic Acid Mouth Rinse Author(s): Donnelly Ronald F
Sep/Oct 2018 Pg. 417-423	Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Author(s): Nalenz Heiko, Köpf Ellen, Dietel Elke
Sep/Oct 2018 Pg. 424-432	A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier Author(s): Songkro Sarunyoo, Pengmak Somuredee, Seajung Pornyamol, Maneenuan Duangkhae, Kaewnopparat Nattha
Sep/Oct 2018 Pg. 433-439	Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding Author(s): Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
Nov/Dec 2018 Pg. 444	PreScription: Standardized Concentrations: Pro or Con? Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 446-454	Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Author(s): Zur Eyal
Nov/Dec 2018 Pg. 456-465	Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome Author(s): Riepl Mike
Nov/Dec 2018 Pg. 466-468	Case Study: Absorption of Testosterone Cream via Scrotal Delivery Author(s): Needham Shawn, Needham Shane
Nov/Dec 2018 Pg. 471-473	Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy Author(s): Waldschmidt Ryan
Nov/Dec 2018 Pg. 475-478	Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Author(s): Martin Matt
Nov/Dec 2018 Pg. 480-489	Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review Author(s): Cutaia Kara, Chablani Lipika, Zhao Fang
Nov/Dec 2018 Pg. 490	Calculations Author(s): Stockton Shelly J
Nov/Dec 2018 Pg. 492	Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 493	Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 494	Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 495	Hydrocortisone 2 mg/mL in Inorpha Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 497	Prednisone 5 mg/mL ir Oral Mix Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 498-503	Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Nov/Dec 2018 Pg. 504-511	Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Author(s): Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
Nov/Dec 2018 Pg. 512-515	Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience Author(s): Apolinário Régis De Souza, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018 Pg. 527	Errata Author(s): Allen Loyd V Jr